Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Crossover designs for clinical trials

K C Carriere1

  • 1Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada.

Statistics in Medicine
|May 30, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extended Clopidogrel Therapy Beyond 12 Months and Long-Term Outcomes in Patients With Diabetes Mellitus Receiving Coronary Arterial Second-Generation Drug-Eluting Stents.

The American journal of cardiology·2018
Same author

Off-Pump Coronary Artery Bypass Graft Versus Drug-Eluting Stent Implantation in Patients with Multivessel Disease Involving the Right Coronary Artery.

The Thoracic and cardiovascular surgeon·2018
Same author

Impact of different nitrate therapies on long-term clinical outcomes of patients with vasospastic angina: A propensity score-matched analysis.

International journal of cardiology·2017
Same author

Detecting and correcting for publication bias in meta-analysis - A truncated normal distribution approach.

Statistical methods in medical research·2016
Same author

Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients.

International journal of chronic obstructive pulmonary disease·2016
Same author

Clinical implications of low-dose aspirin on vasospastic angina patients without significant coronary artery stenosis; a propensity score-matched analysis.

International journal of cardiology·2016
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

Three-period crossover designs offer greater efficiency for comparing treatments in clinical trials. These designs significantly reduce variability and handle missing data better than traditional two-period designs.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Experimental Design

Background:

  • Clinical trials frequently face practical limitations impacting design efficiency.
  • Two-period crossover designs can present challenges if trials terminate early.
  • Residual treatment effects and interactions require careful consideration in trial design.

Purpose of the Study:

  • To propose a subset of three-period crossover designs robust to early termination.
  • To demonstrate the enhanced efficiency of three-period designs over two-period designs.
  • To evaluate design suitability under complex residual effect assumptions and missing data.

Main Methods:

  • Analysis of three-period crossover designs, including specific sequence subsets.
  • Comparison of variability in estimating direct and residual treatment effects.

Related Experiment Videos

  • Assessment of design robustness against second-order residual effects and treatment-period interactions.
  • Evaluation of performance with missing data.

    • Main Results:

    • Three-period designs show a dramatic reduction in variability compared to two-period designs.
    • Universally optimal two-sequence designs are unsuitable for complex residual effects.
    • A four-sequence (ABB, BAA, AAB, BBA) three-period design is robust to model uncertainties.
    • Three-period designs remain highly efficient even with substantial missing data.

    Conclusions:

    • Three-period crossover designs provide a more efficient and robust alternative to two-period designs in clinical trials.
    • Specific sequence selection is crucial for handling complex residual effects.
    • Three-period designs offer a significant advantage in managing missing data, enhancing trial reliability.